Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +47.86%
#3 Velvet Velvet +43.20%
#4 Akedo Akedo +42.96%
#5 Black Phoenix Black Phoenix +34.22%
#6 Cross Cross +21.95%
#7 DoubleZero DoubleZero +17.10%
#8 Cap Cap +16.75%
#9 Tutorial Tutorial +15.51%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.76%
Coin of the day
Islamic Coin Islamic Coin
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Hisse Senetlerindeki Sıralama #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Hisse Fiyatı
$0.11725176
Son senkronizasyon: 2025-07-14
Piyasa Değeri
$481.50K
Değişim (1 gün)
-0.20%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret PHAXIAM Therapeutics S.A. (PHXM)

Kategori

Healthcare
PHAXIAM Therapeutics S.A. (PHXM) için P/B oranı
August 2026 itibarıyla P/B oranı TTM: 0.02
PHAXIAM Therapeutics S.A. şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 0.02'dir. 2022 yılının sonunda şirketin P/B oranı 0.48 idi.
PHAXIAM Therapeutics S.A. için P/B oranı geçmişi 2016 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
2026 (TTM) 0.02 -97.64%
2023 0.78 60.84%
2022 0.48 -77.96%
2021 2.20 -55.37%
2020 4.93 250.70%
2019 1.40 82.40%
2018 0.77 -33.59%
2017 1.16 -62.33%
2016 3.08 0.00%
Benzer şirketler veya rakipler için P/B oranı
Şirket P/B Oranı P/B Oranı Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 33,928.80%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 34,401.63%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 19,650.00%
BE